Number of respondents by (selected*) first cancer site and date of diagnosis: Medicare Advantage

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 48,758 16,871 34.60 7,423 15.22 7,411 15.20 10,062 20.64 6,991 14.34
Breast 47,047 17,646 37.51 6,144 13.06 5,943 12.63 8,098 17.21 9,216 19.59
Colorectal 28,023 14,343 51.18 3,529 12.59 2,904 10.36 3,628 12.95 3,619 12.91
Lung and Bronchus 27,438 21,719 79.16 2,793 10.18 1,268 4.62 1,023 3.73 635 2.31
Melanoma Skin 15,399 7,269 47.20 1,946 12.64 1,867 12.12 2,136 13.87 2,181 14.16
Bladder 14,782 8,241 55.75 1,889 12.78 1,537 10.40 1,674 11.32 1,441 9.75
Non-Hodgkins Lymphoma 9,905 5,649 57.03 1,231 12.43 1,014 10.24 1,114 11.25 897 9.06
Uterine Corpus 8,250 2,986 36.19 961 11.65 999 12.11 1,339 16.23 1,965 23.82
Kidney/Renal Pelvis 7,084 3,740 52.80 939 13.26 838 11.83 901 12.72 666 9.40
Head/Neck 6,718 3,298 49.09 923 13.74 727 10.82 902 13.43 868 12.92
Leukemia 5,992 3,776 63.02 838 13.99 486 8.11 561 9.36 331 5.52
Pancreas 5,437 4,890 89.94 352 6.47 99 1.82 63 1.16 33 0.61
Stomach 3,448 2,424 70.30 411 11.92 202 5.86 225 6.53 186 5.39
Ovary 2,913 1,633 56.06 354 12.15 233 8.00 252 8.65 441 15.14
Liver/Bile Duct 2,650 2,138 80.68 265 10.00 120 4.53 88 3.32 39 1.47
Esophagus 1,863 1,438 77.19 193 10.36 105 5.64 88 4.72 39 2.09
Uterine Cervix 1,056 335 31.72 87 8.24 97 9.19 157 14.87 380 35.98

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 03 Jun, 2021